STANCHART (02888) Announces Q3 Results: Profit Before Tax US$2.3 Billion, Up 29% Year-on-Year
Standard Chartered (02888) announced its Q3 2026 results. On a reported basis, operating income rose 14% to US$5.8 billion; net interest income rose 9% to US$3 billion, driven by trading volumes and balance sheet portfolio optimization; profit before tax was US$2.3 billion, up 29%.
STANCHART (02888) Announces Q3 2026 Results: On a reported basis, operating income rose 14% to US$5.8 billion; net interest income rose 9% to US$3 billion, driven by trading volumes and optimization of the balance sheet mix; profit before tax was US$2.3 billion, up 29%.
Group Chief Executive Bill Winters said: "We delivered another strong quarter, with broad-based growth across all businesses, and earnings per share up 27% year-to-date. We have long believed that the structural shifts in trade, investment and wealth creation would present enormous opportunities for Standard Chartered, and this quarter's performance further confirms that we are successfully capturing these opportunities. Our stable and comprehensive performance reflects the strength of the Group's businesses and disciplined execution, giving us the confidence to raise our 2026 income guidance; we now expect 2026 return on tangible equity to be approximately 14%."
Related Articles

TIANGONG INT'L (00826) Secures First Nuclear Fusion Materials Order, Marking Key Milestone in Its High-End Strategy

Suzhou Dongshan Precision Manufacturing (02384) Debut: Favored by Investors, "AI PCB + Optical Modules" Accelerate Valuation Reshaping

Medical device sector rally combined with share buybacks providing sentiment supportis AK MEDICAL (01789) reaching a stock price rebound point?
TIANGONG INT'L (00826) Secures First Nuclear Fusion Materials Order, Marking Key Milestone in Its High-End Strategy

Suzhou Dongshan Precision Manufacturing (02384) Debut: Favored by Investors, "AI PCB + Optical Modules" Accelerate Valuation Reshaping

Medical device sector rally combined with share buybacks providing sentiment supportis AK MEDICAL (01789) reaching a stock price rebound point?






